Forward Pharma A/S (NASDAQ:FWP) Upgraded at ValuEngine

ValuEngine upgraded shares of Forward Pharma A/S (NASDAQ:FWP) from a strong sell rating to a sell rating in a research report released on Friday morning, ValuEngine reports.

Shares of NASDAQ:FWP opened at $1.02 on Friday. The business has a fifty day moving average price of $0.95 and a two-hundred day moving average price of $1.04. Forward Pharma A/S has a 1 year low of $0.71 and a 1 year high of $2.86.

About Forward Pharma A/S

Forward Pharma A/S operates as a biopharmaceutical company. The company focuses on developing FP187, a proprietary formulation of dimethyl fumarate used for the treatment of various inflammatory and neurological indications. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.

Read More: What is the Bid-Ask Spread?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Forward Pharma A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forward Pharma A/S and related companies with MarketBeat.com's FREE daily email newsletter.